These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11572178)

  • 61. ASHP policy on the acceptance of advertising.
    Am J Hosp Pharm; 1992 Jan; 49(1):160-1. PubMed ID: 1442809
    [No Abstract]   [Full Text] [Related]  

  • 62. Advertising and clinical investigation.
    Ciaglia P; Levy H; Ryan TF
    Chest; 1990 Nov; 98(5):1309-10. PubMed ID: 2225998
    [No Abstract]   [Full Text] [Related]  

  • 63. Editorial: Drug advertisement.
    Overstreet AE
    J Ky Med Assoc; 1974 Apr; 72(4):219. PubMed ID: 4821476
    [No Abstract]   [Full Text] [Related]  

  • 64. Trojan horse advertising.
    Friedman JH
    Med Health R I; 1999 May; 82(5):150. PubMed ID: 10343487
    [No Abstract]   [Full Text] [Related]  

  • 65. Pharmaceutical advertisement claims in Australian medical publications.
    Loke TW; Koh FC; Ward JE
    Med J Aust; 2002 Sep; 177(6):291-3. PubMed ID: 12225274
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Misleading facts in an advertisement of an antidepressive agent].
    Mattsson B
    Lakartidningen; 1997 Mar; 94(12):1051-2. PubMed ID: 9121233
    [No Abstract]   [Full Text] [Related]  

  • 67. Advertisement scrutiny.
    Lexchin J
    Lancet; 1987 Jun; 1(8545):1323-4. PubMed ID: 2884447
    [No Abstract]   [Full Text] [Related]  

  • 68. Drug reps are marketers, period.
    Williams R
    Health Aff (Millwood); 2002; 21(4):297-8; author reply 298-9. PubMed ID: 12117147
    [No Abstract]   [Full Text] [Related]  

  • 69. Advertising principles.
    Hogan D
    Arch Dermatol; 1994 Oct; 130(10):1328. PubMed ID: 7944521
    [No Abstract]   [Full Text] [Related]  

  • 70. The art and science of marketing medications.
    Toop L; Mangin D
    N Z Med J; 2015 Sep; 128(1421):11-2. PubMed ID: 26370750
    [No Abstract]   [Full Text] [Related]  

  • 71. Is our focus on pharmaceutical company influence too narrow?
    Gravatt L
    N Z Med J; 2015 Sep; 128(1422):83-4. PubMed ID: 26411855
    [No Abstract]   [Full Text] [Related]  

  • 72. [Alcohol and tonic--a suitable remedy?].
    Allander E
    Lakartidningen; 1968 Feb; 65(6):543-8. PubMed ID: 5723554
    [No Abstract]   [Full Text] [Related]  

  • 73. [Letter: Negative advertisement].
    Boréus L
    Lakartidningen; 1976 May; 73(19):1810-1. PubMed ID: 1271906
    [No Abstract]   [Full Text] [Related]  

  • 74. Unpublished data in drug advertisements.
    Humphreys DM
    BMJ; 1993 Apr; 306(6885):1127. PubMed ID: 8495175
    [No Abstract]   [Full Text] [Related]  

  • 75. A positive health strategy for the office waiting room.
    Richards JW
    N Y State J Med; 1983 Dec; 83(13):1358-60. PubMed ID: 6582396
    [No Abstract]   [Full Text] [Related]  

  • 76. Report of specific cardiovascular outcomes of the ADVANTAGE trial.
    Egilman DS; Presler AH
    Ann Intern Med; 2006 May; 144(10):781. PubMed ID: 16702599
    [No Abstract]   [Full Text] [Related]  

  • 77. "Precious baby".
    Cromer MA
    N Y State J Med; 1983 Dec; 83(13):1292-3. PubMed ID: 6582375
    [No Abstract]   [Full Text] [Related]  

  • 78. Risks and benefits of calcium antagonists.
    Schubert T
    Lancet; 1995 Oct; 346(8980):961. PubMed ID: 7564739
    [No Abstract]   [Full Text] [Related]  

  • 79. Letter: Misleading drug advertising.
    Jouhar AJ
    Br Med J; 1975 Apr; 2(5961):38. PubMed ID: 1137785
    [No Abstract]   [Full Text] [Related]  

  • 80. [Deceptive publicity].
    Bonard EC
    Rev Med Suisse Romande; 1999 Apr; 119(4):345-7. PubMed ID: 10361474
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.